These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Analytical Assessment of the Vela Diagnostics NGS Assay for HIV Genotyping and Resistance Testing: The Apulian Experience. Bonifacio MA; Genchi C; Lagioia A; Talamo V; Volpe A; Mariggiò MA Int J Mol Sci; 2022 Mar; 23(5):. PubMed ID: 35269868 [TBL] [Abstract][Full Text] [Related]
23. Performance comparison of next generation sequencing analysis pipelines for HIV-1 drug resistance testing. Lee ER; Parkin N; Jennings C; Brumme CJ; Enns E; Casadellà M; Howison M; Coetzer M; Avila-Rios S; Capina R; Marinier E; Van Domselaar G; Noguera-Julian M; Kirkby D; Knaggs J; Harrigan R; Quiñones-Mateu M; Paredes R; Kantor R; Sandstrom P; Ji H Sci Rep; 2020 Jan; 10(1):1634. PubMed ID: 32005884 [TBL] [Abstract][Full Text] [Related]
24. Detection of Viruses in Clinical Samples by Use of Metagenomic Sequencing and Targeted Sequence Capture. Wylie KM; Wylie TN; Buller R; Herter B; Cannella MT; Storch GA J Clin Microbiol; 2018 Dec; 56(12):. PubMed ID: 30232133 [TBL] [Abstract][Full Text] [Related]
25. Comparison of targeted next-generation sequencing for whole-genome sequencing of Hantaan orthohantavirus in Apodemus agrarius lung tissues. No JS; Kim WK; Cho S; Lee SH; Kim JA; Lee D; Song DH; Gu SH; Jeong ST; Wiley MR; Palacios G; Song JW Sci Rep; 2019 Nov; 9(1):16631. PubMed ID: 31719616 [TBL] [Abstract][Full Text] [Related]
26. geno2pheno[ngs-freq]: a genotypic interpretation system for identifying viral drug resistance using next-generation sequencing data. Döring M; Büch J; Friedrich G; Pironti A; Kalaghatgi P; Knops E; Heger E; Obermeier M; Däumer M; Thielen A; Kaiser R; Lengauer T; Pfeifer N Nucleic Acids Res; 2018 Jul; 46(W1):W271-W277. PubMed ID: 29718426 [TBL] [Abstract][Full Text] [Related]
27. Applications of Probe Capture Enrichment Next Generation Sequencing for Whole Mitochondrial Genome and 426 Nuclear SNPs for Forensically Challenging Samples. Shih SY; Bose N; Gonçalves ABR; Erlich HA; Calloway CD Genes (Basel); 2018 Jan; 9(1):. PubMed ID: 29361782 [TBL] [Abstract][Full Text] [Related]
28. Routine drug resistance testing in HIV-1 proviral DNA, using an automated next- generation sequencing assay. Alidjinou EK; Coulon P; Hallaert C; Robineau O; Meybeck A; Huleux T; Ajana F; Hober D; Bocket L J Clin Virol; 2019 Dec; 121():104207. PubMed ID: 31707202 [TBL] [Abstract][Full Text] [Related]
29. HCV genotyping from NGS short reads and its application in genotype detection from HCV mixed infected plasma. Qiu P; Stevens R; Wei B; Lahser F; Howe AY; Klappenbach JA; Marton MJ PLoS One; 2015; 10(4):e0122082. PubMed ID: 25830316 [TBL] [Abstract][Full Text] [Related]
31. CODEHOP-Mediated PCR Improves HIV-1 Genotyping and Detection of Variants by MinION Sequencing. Sarkhouh H; Chehadeh W Microbiol Spectr; 2021 Oct; 9(2):e0143221. PubMed ID: 34668751 [TBL] [Abstract][Full Text] [Related]
32. Technologies for HIV-1 drug resistance testing: inventory and needs. Metzner KJ Curr Opin HIV AIDS; 2022 Jul; 17(4):222-228. PubMed ID: 35762377 [TBL] [Abstract][Full Text] [Related]
33. Limited Marginal Utility of Deep Sequencing for HIV Drug Resistance Testing in the Age of Integrase Inhibitors. Dalmat RR; Makhsous N; Pepper GG; Magaret A; Jerome KR; Wald A; Greninger AL J Clin Microbiol; 2018 Dec; 56(12):. PubMed ID: 30305383 [TBL] [Abstract][Full Text] [Related]
34. Targeted Sequencing of Respiratory Viruses in Clinical Specimens for Pathogen Identification and Genome-Wide Analysis. Yang Y; Walls SD; Gross SM; Schroth GP; Jarman RG; Hang J Methods Mol Biol; 2018; 1838():125-140. PubMed ID: 30128994 [TBL] [Abstract][Full Text] [Related]
35. Sequencing-based detection of low-frequency human immunodeficiency virus type 1 drug-resistant mutants by an RNA/DNA heteroduplex generator-tracking assay. Kapoor A; Jones M; Shafer RW; Rhee SY; Kazanjian P; Delwart EL J Virol; 2004 Jul; 78(13):7112-23. PubMed ID: 15194787 [TBL] [Abstract][Full Text] [Related]
36. ve-SEQ: Robust, unbiased enrichment for streamlined detection and whole-genome sequencing of HCV and other highly diverse pathogens. Bonsall D; Ansari MA; Ip C; Trebes A; Brown A; Klenerman P; Buck D; ; Piazza P; Barnes E; Bowden R F1000Res; 2015; 4():1062. PubMed ID: 27092241 [TBL] [Abstract][Full Text] [Related]
37. A MiSeq-HyDRA platform for enhanced HIV drug resistance genotyping and surveillance. Taylor T; Lee ER; Nykoluk M; Enns E; Liang B; Capina R; Gauthier MK; Domselaar GV; Sandstrom P; Brooks J; Ji H Sci Rep; 2019 Jun; 9(1):8970. PubMed ID: 31222149 [TBL] [Abstract][Full Text] [Related]
38. Best approaches to drug-resistance surveillance at the country level. Cabibbe AM; Cirillo DM Int J Mycobacteriol; 2016 Dec; 5 Suppl 1():S40-S41. PubMed ID: 28043601 [TBL] [Abstract][Full Text] [Related]
39. RNA and DNA Sanger sequencing versus next-generation sequencing for HIV-1 drug resistance testing in treatment-naive patients. Alidjinou EK; Deldalle J; Hallaert C; Robineau O; Ajana F; Choisy P; Hober D; Bocket L J Antimicrob Chemother; 2017 Oct; 72(10):2823-2830. PubMed ID: 29091197 [TBL] [Abstract][Full Text] [Related]
40. Targeted Enrichment for Pathogen Detection and Characterization in Three Felid Species. Lee JS; Mackie RS; Harrison T; Shariat B; Kind T; Kehl T; Löchelt M; Boucher C; VandeWoude S J Clin Microbiol; 2017 Jun; 55(6):1658-1670. PubMed ID: 28330894 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]